MICHELLE THOMAS: Open Payments
NPI 1144713280 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 51 payments from 14 companies in 2025. Trend: 2023 $22 · 2024 $991 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 11 | $235 |
| Lilly USA, LLC | 14 | $208 |
| Astellas Pharma US Inc | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $109 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| MILLICENT US INC | 4 | $69 |
| PFIZER INC. | 2 | $46 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Organon LLC | 3 | $44 |
| ABBVIE INC. | 2 | $35 |
Products named: Veozah, ANNOVERA, ZEPBOUND, MOUNJARO, MYFEMBREE, NURTEC ODT, NEXPLANON, INTRAROSA.
Industry payments across NC — which companies pay providers there.
